Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-25-175003
Filing Date
2025-08-07
Accepted
2025-08-07 08:26:16
Documents
21

Document Format Files

Seq Description Document Type Size
1 S-3 d29883ds3.htm S-3 579856
2 EX-1.2 d29883dex12.htm EX-1.2 183473
3 EX-4.4 d29883dex44.htm EX-4.4 289031
4 EX-4.5 d29883dex45.htm EX-4.5 285505
5 EX-5.1 d29883dex51.htm EX-5.1 15929
6 EX-5.2 d29883dex52.htm EX-5.2 9211
7 EX-23.1 d29883dex231.htm EX-23.1 1700
8 EX-FILING FEES d29883dexfilingfees.htm   iXBRL EX-FILING FEES 69679
9 GRAPHIC g29883g0805112525711.jpg GRAPHIC 2661
10 GRAPHIC g29883g0805113023565.jpg GRAPHIC 2594
11 GRAPHIC g29883g39r43.jpg GRAPHIC 28168
  Complete submission text file 0001193125-25-175003.txt   1664673

Data Files

Seq Description Document Type Size
24 EXTRACTED XBRL INSTANCE DOCUMENT d29883dexfilingfees_htm.xml XML 34829
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-289339 | Film No.: 251191779
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)